Prestige Consumer Healthcare Inc.
PBH
$84.88
$1.191.42%
| Weiss Ratings | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Good | |||
| Risk Grade | B- | |||
| Reward Grade | B | |||
| Rating Factors | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.35 | |||
| Price History | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.54% | |||
| 30-Day Total Return | 10.56% | |||
| 60-Day Total Return | 3.52% | |||
| 90-Day Total Return | 14.63% | |||
| Year to Date Total Return | 9.21% | |||
| 1-Year Total Return | 13.67% | |||
| 2-Year Total Return | 40.90% | |||
| 3-Year Total Return | 50.74% | |||
| 5-Year Total Return | 180.32% | |||
| 52-Week High % Change | -7.05% | |||
| 52-Week Low % Change | 34.23% | |||
| Price | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $90.04 | |||
| 52-Week Low Price | $62.35 | |||
| 52-Week Low Price (Date) | May 30, 2024 | |||
| 52-Week High Price (Date) | Mar 10, 2025 | |||
| Valuation | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.15B | |||
| Enterprise Value | 5.12B | |||
| Price/Earnings (TTM) | 19.60 | |||
| Earnings Per Share (TTM) | 4.27 | |||
| Earnings Per Share Growth | -360.27% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.74 | |||
| Price/Book (Q) | 2.32 | |||
| Enterprise Value/Revenue (TTM) | 4.58 | |||
| Price | $84.88 | |||
| Enterprise Value/EBITDA (TTM) | 14.18 | |||
| Enterprise Value/EBIT | 15.50 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.99M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 914 524 6800 | |||
| Address | 660 White Plains Road Tarrytown, NY 10591 | |||
| Website | www.prestigebrands.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 29.55% | |||
| Profit Margin | 19.13% | |||
| Management Effectiveness | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.19% | |||
| Return on Equity | 12.63% | |||
| Income Statement | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.12B | |||
| Total Revenue (TTM) | 1.12B | |||
| Revenue Per Share | $22.37 | |||
| Gross Profit (TTM) | 625.12M | |||
| EBITDA (TTM) | 361.26M | |||
| EBIT (TTM) | 330.50M | |||
| Net Income (TTM) | 213.94M | |||
| Net Income Avl. to Common (TTM) | 213.94M | |||
| Total Revenue Growth (Q YOY) | 2.68% | |||
| Earnings Growth (Q YOY) | 15.05% | |||
| EPS Diluted (TTM) | 4.27 | |||
| EPS Diluted Growth (Q YOY) | 15.09% | |||
| Balance Sheet | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 50.87M | |||
| Cash Per Share (Q) | $1.02 | |||
| Total Current Assets (Q) | 377.16M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.79B | |||
| Current Ratio (Q) | 3.678 | |||
| Book Value Per Share (Q) | $36.07 | |||
| Total Assets (Q) | 3.33B | |||
| Total Current Liabilities (Q) | 102.55M | |||
| Total Debt (Q) | 1.03B | |||
| Total Liabilities (Q) | 1.54B | |||
| Total Common Equity (Q) | 1.79B | |||
| Cash Flow | PBH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -28.98M | |||
| Cash from Financing (TTM) | -239.03M | |||
| Net Change in Cash (TTM) | -12.74M | |||
| Levered Free Cash Flow (TTM) | 191.75M | |||
| Cash from Operations (TTM) | 256.57M | |||
